Morning Briefing
Summaries of health policy coverage from major news organizations
Drug Industry: Pharmaceutical Companies Find Ways To Cope As Patents Expire; FDA Criticized For Consulting Contracts
Patent losses are forcing drug companies to cut costs and look to other markets.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
